Skip to main content
Clinical Trials/ISRCTN75989485
ISRCTN75989485
Completed
未知

Development and implementation of a patient-centred peer support intervention to promote the detection, reporting and management of adverse drug reactions among people living with HIV in Uganda

Makerere University0 sites660 target enrollmentJune 2, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Pharmacovigilance among people living with HIV
Sponsor
Makerere University
Enrollment
660
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35589351/ (added 23/05/2022)

Registry
who.int
Start Date
June 2, 2021
End Date
June 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Accessible PLHIV aged 15 years and older
  • 2\. Receiving antiretroviral therapy at the study sites
  • 3\. Own a mobile phone (smartphone or basic feature phone)
  • 4\. Provide written/thumb\-printed informed consent
  • Community health workers and expert clients recognized and seconded by the study sites or patient safety groups, who own mobile phones

Exclusion Criteria

  • 1\. PLHIV who will have received antiretroviral therapy for less than 6 months
  • 2\. Community health workers and expert clients who are unable to commit at least 4 months to the study

Outcomes

Primary Outcomes

Not specified

Similar Trials